# Igenesis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/igenesis

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.igenesisbio.com
- Total disclosed funding: $8.5M
- Latest round: Series B (Mar 29, 2020)
- Investors on record: 1

## About

Founded in 2015 and based in Shanghai, China, Igenesis operates as a medical devices manufacturer that focuses on the production and sales of automated bioassay products. It was recognized as the National High-tech Enterprise. The company has a reagent R&D center in Guangzhou and an automated production center in Shenzhen, with an existing office, R&D and production area of over 8,000 square meters, as well as approximately 200 employees. The company acquired 9 Chinese medical device registration certificates and record certificates, 21 EU CE certificates and ISO 13485 quality system certification. In March 2020, Igenesis raised a series B funding for CNY 60 million from new investor Shenzhen Capital Group.

Igenesis's main business is the research, development, production, and sales of automated bioassays and related products. Its products include automated assays, reagents and reagent smart boxes, etc. Its Sniffer Orion is a 24-channel DNA extraction device that allows automated DNA extraction and purification of samples in less than 30 minutes. Products mainly serve medical institutions, CDC, third-party clinical inspection agencies, forensic centers, inspection and quarantine bureaus and so on.

The company generates revenue by selling automated assays, reagents, reagent smart boxes, and other products.

## Funding rounds

- Series B, Mar 29, 2020, $8.5M — Shenzhen Capital Real Estate Fund

## Investors

- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Series B